Khalid Al Hawsawi, et al. “Omalizumab in Chronic Spontaneous Urticaria: Assessment of Response in Twenty-Five Patients”. Dermatology, vol. 7, no. 1, Jan. 2022, pp. 1-5, doi:10.17140/DRMTOJ-7-147.